Introduced:
Mar 27, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
3
Actions
1
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Mar 27, 2025
Referred to the House Committee on Energy and Commerce.
Actions (3)
Referred to the House Committee on Energy and Commerce.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Mar 27, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: Intro-H
Mar 27, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1000
Mar 27, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (1)
(D-IL)
Mar 27, 2025
Mar 27, 2025
Full Bill Text
Length: 2,526 characters
Version: Introduced in House
Version Date: Mar 27, 2025
Last Updated: Nov 14, 2025 6:26 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2404 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 2404
To provide for a study on the effects of remote monitoring on
individuals who are prescribed opioids.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 27, 2025
Mr. Balderson (for himself and Ms. Kelly of Illinois) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To provide for a study on the effects of remote monitoring on
individuals who are prescribed opioids.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[H.R. 2404 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 2404
To provide for a study on the effects of remote monitoring on
individuals who are prescribed opioids.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 27, 2025
Mr. Balderson (for himself and Ms. Kelly of Illinois) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To provide for a study on the effects of remote monitoring on
individuals who are prescribed opioids.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Remote Opioid Monitoring Act of
2025''.
SEC. 2.
INDIVIDUALS WHO ARE PRESCRIBED OPIOIDS.
(a) In General.--Not later than 18 months after the date of
enactment of this Act, the Comptroller General of the United States
shall conduct a study and submit to the Committee on Energy and
Commerce of the House of Representatives and the Committee on Health,
Education, Labor, and Pensions and the Committee on Finance of the
Senate a report on the use of remote monitoring with respect to
individuals who are prescribed opioids.
(b) Report.--The report described in subsection
(a) shall include--
(1) an assessment of scientific evidence related to the
efficacy, individual outcomes, and potential cost savings
associated with remote monitoring for individuals who are
prescribed opioids compared to such individuals who are not so
monitored;
(2) an assessment of the current prevalence of remote
monitoring for individuals who are prescribed opioids,
including the use of such monitoring for such individuals in
other countries; and
(3) recommendations to improve availability, access, and
coverage for remote monitoring for individuals who are
prescribed opioids, including through changes to Federal health
care programs (as defined in
(a) In General.--Not later than 18 months after the date of
enactment of this Act, the Comptroller General of the United States
shall conduct a study and submit to the Committee on Energy and
Commerce of the House of Representatives and the Committee on Health,
Education, Labor, and Pensions and the Committee on Finance of the
Senate a report on the use of remote monitoring with respect to
individuals who are prescribed opioids.
(b) Report.--The report described in subsection
(a) shall include--
(1) an assessment of scientific evidence related to the
efficacy, individual outcomes, and potential cost savings
associated with remote monitoring for individuals who are
prescribed opioids compared to such individuals who are not so
monitored;
(2) an assessment of the current prevalence of remote
monitoring for individuals who are prescribed opioids,
including the use of such monitoring for such individuals in
other countries; and
(3) recommendations to improve availability, access, and
coverage for remote monitoring for individuals who are
prescribed opioids, including through changes to Federal health
care programs (as defined in
section 1128B of the Social
Security Act (42 U.
Security Act (42 U.S.C. 1320a-7b)) and, if determined
appropriate by the Comptroller General, an identification of
cohorts of individuals who stand to benefit the most from
remote monitoring when prescribed opioids.
<all>
appropriate by the Comptroller General, an identification of
cohorts of individuals who stand to benefit the most from
remote monitoring when prescribed opioids.
<all>